Pancreatic cancer
Conditions
Interventions
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 76 Years
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years old; 2. There is definite histopathological or cytological pathological diagnosis. The TNM stage of AJCC pancreatic cancer is stage IV, or combined with the history, clinical manifestations, laboratory examination and imaging examination, the preliminary clinical diagnosis should be made carefully after discussion by MDT, and the evaluable metastatic pancreatic duct adenocarcinoma that has not received chemotherapy in the past; 3. Patients with ECoG score of 0-2, referring to Zps standard of Eastern Cooperative Oncology Group (Zps); 4. Adequate bone marrow function (granulocyte count >= 1500 / m3, platelet count >= 100000 / m3), liver function (bilirubin <=1.5 times the upper limit of normal range) and renal function.
Exclusion criteria
Exclusion criteria: 1. Patients over 76 years old; 2. Patients with pancreatic endocrine tumor, acinar epithelial tumor, mature teratoma, mesenchymal tumor, malignant lymphoma and secondary tumor; 3. The assessable lesions had received radiotherapy, brain metastasis, other malignant tumors, active infection, chronic diarrhea, history of heart with significant clinical impact, pregnancy or lactation; 4. Patients known to be allergic to the study drug; 5. Patients undergoing other drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival time;Quality of life; | — |
Secondary
| Measure | Time frame |
|---|---|
| ECOG;CA19-9;Sum of the longest tumor diameter; | — |
Countries
China
Contacts
Public ContactBo Pang
Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Outcome results
None listed